Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Mao-Rong Wang"'
Publikováno v:
Infrared Physics & Technology. :104758
Publikováno v:
World Journal of Gastroenterology
Chronic hepatitis B virus (HBV) infection (CHB) is a public health concern worldwide. Current therapies utilizing nucleos(t)ide analogs (NA) have not resulted in a complete cure for CHB. Furthermore, patients on long-term NA treatment often develop l
Autor:
Xu Min Zhao, Bo Wei, George J. Hanna, Zhong Ping Duan, Sheng Mei Mu, Ji Dong Jia, Lai Wei, Paul Ingravallo, Peggy Hwang, Zhan Sheng Jia, Li Wen Liang, Michael N. Robertson, Wen Xie, Ying Ren Zhao, Shan Ming Wu, Rohit Talwani, Wen Xiang Huang, Amy Puenpatom, Yan Huang, Ernest Asante-Appiah, Barbara Evans, Ming Xiang Zhang, Mao Rong Wang, Jun Qi Niu, Fu-Sheng Wang, Zaiqi Wang
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
Background and Aim In China, clinical experience with direct‐acting antiviral treatments for hepatitis C virus (HCV) infection is still emerging. C‐CORAL is a phase 3, multinational, placebo‐controlled, double‐blind trial of elbasvir/grazopre
Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trial
Autor:
Jie Ting Tang, Yi Min Mao, Zheng-Hua Wang, Jun Cheng, Chengwei Chen, Min De Zeng, Jun Qi Niu, Zhong Wei, Qing Xie, Yong Feng Wang, Yong Ping Yang, Wei Jiang Ye, Qing Mao, Mao Rong Wang, Ying Xuan Chen, Hui Guo Ding, Tao Han
Publikováno v:
Journal of Digestive Diseases. 19:144-154
OBJECTIVE To evaluate tolvaptan as a novel therapeutic option for Chinese patients with liver cirrhosis-associated ascites in a phase 2 clinical trial. METHODS This randomized, double-blind, placebo-controlled, multicenter trial was conducted in pati
Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trial
Autor:
Yong Feng, Wang, Jie Ting, Tang, Tao, Han, Hui Guo, Ding, Wei Jiang, Ye, Mao Rong, Wang, Jun, Cheng, Yong Ping, Yang, Cheng Wei, Chen, Qing, Xie, Qing, Mao, Jun Qi, Niu, Zheng Hua, Wang, Zhong, Wei, Ying Xuan, Chen, Min De, Zeng, Yi Min, Mao
Publikováno v:
Journal of digestive diseases. 19(3)
To evaluate tolvaptan as a novel therapeutic option for Chinese patients with liver cirrhosis-associated ascites in a phase 2 clinical trial.This randomized, double-blind, placebo-controlled, multicenter trial was conducted in patients with insuffici
Autor:
Liang Chen, Rui Hua, Yinong Ye, Dongliang Li, Qin Ning, Jun Li, Yingren Zhao, Youwen Tan, Jidong Jia, Sujun Zheng, Jinzi Wu, Zuojong Gong, Jifang Sheng, Dongliang Yang, Mao-rong Wang, Wenxiang Huang, Wen Xie, Ping An, Yanhong Yu, Yongfeng Yang, Zhansheng Jia, Chengwei Chen, Qing He, Yi Kang, Qing Xie, Xiaofeng Wen, Yujuan Guan, Xingxiang Yang, Yongguo Li, Yan Huang, Jiming Zhang, Huimin Liu, Xiaoyuan Xu, Yuemin Nan, Fu-Sheng Wang, Guozhong Gong, Bo Ning, Jinlin Hou, Yuanji Ma, Minghua Lin, Lai Wei, Peng Hu, Quan Zhang
Publikováno v:
Journal of Hepatology. 70:e247
Autor:
Wen-cong Li1, Mao-rong Wang2, Ling-bo Kong1, Wei-guang Ren1, Yu-guo Zhang1, Yue-min Nan1 nanyuemin@163.com
Publikováno v:
BMC Infectious Diseases. 2011, Vol. 11 Issue 1, p165-177. 13p.
Publikováno v:
Chinese Chemical Letters. 23:561-564
Eight novel 5,7-disubstituted-2-{5-methyl-3-(4-trifluoromethylphenyl)isoxazol-4-ylcarbonylimino}-2 H -1,2,4-thiadiazolo[2,3- a ]pyrimidines were synthesized by multi-step reactions in yields 68−85%. Reactions were carried out either by ultrasound i
Publikováno v:
World journal of hepatology. 6(6)
The prevalence of hepatitis C virus (HCV) infection in patients on maintenance hemodialysis (MHD) is relatively higher than those without MHD. Chronic HCV infection detrimentally affects the life quality and expectancy, leads to renal transplant reje
Autor:
Jie, Wang, Mao-rong, Wang
Publikováno v:
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 21(3)
To perform a systematic comparative analysis of two different commercial automated systems using chemiluminescence immunoassay to quantitatively detect hepatitis B virus surface antigen (HBsAg) in patient sera.The Elecsys2010 electrical chemiluminesc